Insider Transactions last 24 months for Intellia Therapeutics, Inc.  -  NSDQ: NTLA

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Chase William JDirector08/20/2025APDirectCOM100,000$10.03$1,003,000.00134,693
Dulac Edward J IiiEVP, Chief Financial Officer07/23/2025DSDirectCOM7,462$14.02$104,617.24106,062
Dube Michael PVP, Chief Accounting Officer07/02/2025DSDirectCOM2,503$9.95$24,904.8557,137
Goodman JesseDirector07/01/2025DSDirectCOM1,547$9.23$14,278.8124,359
Clark ElianaEVP, Chief Technical Officer07/01/2025DSDirectCOM1,022$9.82$10,036.0495,369
Goodman JesseDirector06/30/2025DSDirectCOM1,547$9.56$14,789.3225,906
Cohen Fred EDirector06/11/2025AADirectCOM8,000$0.00$0.0057,453
Chase William JDirector06/11/2025AADirectCOM8,000$0.00$0.0034,693
Bhanji MunaDirector06/11/2025AADirectCOM8,000$0.00$0.0027,203
Goff BrianDirector06/11/2025AADirectCOM8,000$0.00$0.0023,409
Goodman JesseDirector06/11/2025AADirectCOM8,000$0.00$0.0027,453
Verwiel FrankDirector06/11/2025AADirectCOM8,000$0.00$0.0025,948
Keresty GeorgiaDirector06/11/2025AADirectCOM8,000$0.00$0.0031,883
Bhanji MunaDirector04/29/2025DSDirectCOM265$8.50$2,252.5019,203
Basta JamesEVP, General Counsel03/04/2025DSDirectCOM2,572$8.99$23,122.28111,925
Clark ElianaEVP, Chief Technical Officer03/04/2025DSDirectCOM679$8.99$6,104.2195,369
Basta JamesEVP, General Counsel03/01/2025AADirectCOM40,000$0.00$0.00114,497
Schultes Birgit CEVP, Chief Scientific Officer03/01/2025AADirectCOM37,600$0.00$0.00105,215
Lebwohl DavidEVP, Chief Medical Officer03/01/2025AADirectCOM43,200$0.00$0.00130,866
Dube Michael PVP, Chief Accounting Officer03/01/2025AADirectCOM14,000$0.00$0.0059,640
Dulac Edward J IiiEVP, Chief Financial Officer03/01/2025AADirectCOM47,200$0.00$0.00113,524
Leonard John MPresident and CEO03/01/2025AADirectCOM136,000$0.00$0.001,077,115
Clark ElianaEVP, Chief Technical Officer03/01/2025AADirectCOM32,000$0.00$0.0096,048
Bhanji MunaDirector01/29/2025DSDirectCOM265$9.97$2,642.0519,468
Clark ElianaEVP, Chief Technical Officer01/03/2025DSDirectCOM7,422$12.18$90,399.9664,048
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel